Use of lupin conglutin for the treatment of type II diabetes
AssigneeIndena S.p.A.
InventorsPaolo Morazzoni, Marcello Duranti
Life of this patent
Estimating the term…
Abstract
A method for the use of lupin conglutin gamma or of proteins showing homology higher than 50% with lupin conglutin gamma, for the preparation of a medicament, food supplements or foods for the treatment of type II diabetes, pharmaceutical and nutritional compositions containing lupin conglutin gamma, and the use of lupin conglutin gamma as therapeutical agent, in particular as hypoglycemizing agent. Lupin conglutin gamma may be used in pure form or in form of extracts, mixtures or concentrates.
Claims9
A method for the preparation of a medicament, food supplements or foods for the treatment of type II diabetes comprising adding an effective amount of lupin conglutin gamma or a protein having homology higher than 50% with lupin conglutin gamma.
A Pharmaceutical or nutritional compositions comprising lupin conglutin gamma or proteins showing homology higher than 50% with lupin conglutin gamma, as active ingredient.
Lupin conglutin gamma as therapeutical agent.
A method for treating type II diabetes in a subject in need of treatment thereof, comprising administering to said subject an effective amount of lupin conglutin gamma or a protein having homology higher than 50% with lupin conglutin gamma.
Dependencies are inferred from the claim text.